类风湿-话题@MedSci

#类风湿#

751篇内容 | 7475人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1334269, encodeId=af9113342697c, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=NICE支持Rinvoq治疗严重的活动性类风湿关节炎, objectType=article, longId=203140, objectId=2361203140f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2361203140f1, replyNumber=0, likeNumber=76, createdTime=2020-11-10, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2361203140f1, moduleTitle=NICE支持Rinvoq治疗严重的活动性类风湿关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2361203140f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334268, encodeId=9f8b1334268e2, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=NEJM：Upadacitinib治疗生物药难治性类风湿关节炎, objectType=article, longId=202158, objectId=6b4b202158b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b4b202158b8, replyNumber=0, likeNumber=100, createdTime=2020-10-17, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b4b202158b8, moduleTitle=NEJM：Upadacitinib治疗生物药难治性类风湿关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4b202158b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334267, encodeId=1ad7133426e17, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, objectType=article, longId=202101, objectId=906420210148, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=906420210148, replyNumber=0, likeNumber=54, createdTime=2020-10-16, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=906420210148, moduleTitle=Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=906420210148)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334266, encodeId=41a71334266d0, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=NEJM：PRIME细胞的RNA鉴定可用于预测类风湿性关节炎耀斑, objectType=article, longId=201984, objectId=4cca20198416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cca20198416, replyNumber=0, likeNumber=57, createdTime=2020-10-13, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cca20198416, moduleTitle=NEJM：PRIME细胞的RNA鉴定可用于预测类风湿性关节炎耀斑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cca20198416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334265, encodeId=f5b913342654d, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标, objectType=article, longId=201820, objectId=4b5c201820da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b5c201820da, replyNumber=0, likeNumber=63, createdTime=2020-10-09, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b5c201820da, moduleTitle=Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b5c201820da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334264, encodeId=4b76133426439, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, objectType=article, longId=201337, objectId=860520133e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=860520133e20, replyNumber=0, likeNumber=125, createdTime=2020-09-30, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=860520133e20, moduleTitle=Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=860520133e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334263, encodeId=8ca0133426354, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准, objectType=article, longId=201256, objectId=8539201256b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8539201256b5, replyNumber=0, likeNumber=60, createdTime=2020-09-28, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8539201256b5, moduleTitle=Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8539201256b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334262, encodeId=1176133426282, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=类风湿关节炎药物Kevzara（sarilumab）无法治疗COVID-19, objectType=article, longId=200396, objectId=76c22003960a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76c22003960a, replyNumber=0, likeNumber=0, createdTime=2020-09-09, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76c22003960a, moduleTitle=类风湿关节炎药物Kevzara（sarilumab）无法治疗COVID-19, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c22003960a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334261, encodeId=395d1334261df, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市, objectType=article, longId=200229, objectId=e99e20022968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99e20022968, replyNumber=0, likeNumber=113, createdTime=2020-09-05, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99e20022968, moduleTitle=中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99e20022968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334260, encodeId=3b4b13342601b, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Lancet Rheumato：羟氯喹治疗类风湿性关节炎安全性研究, objectType=article, longId=199897, objectId=44c619989e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c619989e88, replyNumber=0, likeNumber=65, createdTime=2020-08-26, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c619989e88, moduleTitle=Lancet Rheumato：羟氯喹治疗类风湿性关节炎安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44c619989e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334259, encodeId=a7581334259e6, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis：巴瑞克替尼治疗活动性类风湿性关节炎的感染率, objectType=article, longId=199667, objectId=ae0a19966e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae0a19966e81, replyNumber=0, likeNumber=103, createdTime=2020-08-20, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae0a19966e81, moduleTitle=Ann Rheum Dis：巴瑞克替尼治疗活动性类风湿性关节炎的感染率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae0a19966e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334258, encodeId=019b1334258a7, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Adv Mater：深圳先进院等在类风湿性关节炎诊疗的光声分子成像研究中获进展, objectType=article, longId=199394, objectId=de60199394ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de60199394ed, replyNumber=0, likeNumber=64, createdTime=2020-08-15, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de60199394ed, moduleTitle=Adv Mater：深圳先进院等在类风湿性关节炎诊疗的光声分子成像研究中获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de60199394ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334257, encodeId=7c0c133425ed7, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Ann Rheum Dis："程序化 "英夫利昔单抗（IFX）治疗策略治疗类风湿性关节炎的效果如何？ , objectType=article, longId=198555, objectId=c95e1985552a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95e1985552a, replyNumber=0, likeNumber=81, createdTime=2020-08-03, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95e1985552a, moduleTitle=Ann Rheum Dis："程序化 "英夫利昔单抗（IFX）治疗策略治疗类风湿性关节炎的效果如何？ , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95e1985552a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334256, encodeId=25a3133425604, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Am J Clin Nutr：类风湿关节炎的抗炎饮食（ADIRA）对疾病活动的影响, objectType=article, longId=198552, objectId=3f5c198552c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f5c198552c8, replyNumber=0, likeNumber=118, createdTime=2020-08-03, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f5c198552c8, moduleTitle=Am J Clin Nutr：类风湿关节炎的抗炎饮食（ADIRA）对疾病活动的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f5c198552c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334255, encodeId=6eb21334255df, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性, objectType=article, longId=198545, objectId=0a21198545d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a21198545d5, replyNumber=0, likeNumber=78, createdTime=2020-08-03, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a21198545d5, moduleTitle=Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a21198545d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334254, encodeId=d8eb1334254b6, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=J Rheumatol：腹型肥胖与普通肥胖女性患类风湿性关节炎风险的比较, objectType=article, longId=198343, objectId=7ee419834305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee419834305, replyNumber=0, likeNumber=91, createdTime=2020-07-31, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee419834305, moduleTitle=J Rheumatol：腹型肥胖与普通肥胖女性患类风湿性关节炎风险的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ee419834305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334253, encodeId=fb73133425393, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较 , objectType=article, longId=198335, objectId=666e198335c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=666e198335c9, replyNumber=0, likeNumber=72, createdTime=2020-07-31, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=666e198335c9, moduleTitle=Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=666e198335c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334252, encodeId=e02f1334252e5, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效, objectType=article, longId=198030, objectId=5ec3198030cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ec3198030cb, replyNumber=0, likeNumber=96, createdTime=2020-07-27, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ec3198030cb, moduleTitle=Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ec3198030cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334251, encodeId=24de133425109, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=AP&T: 定期使用质子泵抑制剂和女性类风湿性关节炎的风险, objectType=article, longId=197803, objectId=372319e803d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=372319e803d6, replyNumber=0, likeNumber=110, createdTime=2020-07-21, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=372319e803d6, moduleTitle=AP&T: 定期使用质子泵抑制剂和女性类风湿性关节炎的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=372319e803d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1334250, encodeId=f608133425023, content=<a href='/topic/show?id=5306e6164b6' target=_blank style='color:#2F92EE;'>#类风湿#</a>, objectTitle=NEJM：PRIME细胞与类风湿性关节炎发作, objectType=article, longId=197646, objectId=f76819e646e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f76819e646e6, replyNumber=0, likeNumber=60, createdTime=2020-07-18, rootId=0, userName=ms4964546379600229, userId=6ff22500098, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f76819e646e6, moduleTitle=NEJM：PRIME细胞与类风湿性关节炎发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f76819e646e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

类风湿

2020-05-29

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

NICE支持Rinvoq治疗严重的活动性类风湿关节炎

2020-11-10

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

NEJM：Upadacitinib治疗生物药难治性类风湿关节炎

2020-10-17

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Clin Gastroenterology H:接受免疫抑制治疗的类风湿关节炎患者血清转化逆转的风险低

2020-10-16

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

NEJM：PRIME细胞的RNA鉴定可用于预测类风湿性关节炎耀斑

2020-10-13

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Cell Mol Life Sci：研究发现CCL21是类风湿性关节炎治疗的一个有吸引力的新型靶标

2020-10-09

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Rheumatology：接受JAK抑制剂的类风湿关节炎患者发生严重感染的风险

2020-09-30

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Jyseleca（filgotinib）治疗类风湿性关节炎：已获得日本和欧盟的批准

2020-09-28

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

类风湿关节炎药物Kevzara（sarilumab）无法治疗COVID-19

2020-09-09

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

中国类风湿关节炎患者的福音！阿达木单抗生物类似物SULINNO在中国获准上市

2020-09-05

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Lancet Rheumato：羟氯喹治疗类风湿性关节炎安全性研究

2020-08-26

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis：巴瑞克替尼治疗活动性类风湿性关节炎的感染率

2020-08-20

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Adv Mater：深圳先进院等在类风湿性关节炎诊疗的光声分子成像研究中获进展

2020-08-15

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Ann Rheum Dis："程序化 "英夫利昔单抗（IFX）治疗策略治疗类风湿性关节炎的效果如何？

2020-08-03

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Am J Clin Nutr：类风湿关节炎的抗炎饮食（ADIRA）对疾病活动的影响

2020-08-03

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Arthritis Rheumatol：托西利珠单抗VS依那西普在类风湿关节炎中的心血管安全性

2020-08-03

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

J Rheumatol：腹型肥胖与普通肥胖女性患类风湿性关节炎风险的比较

2020-07-31

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较

2020-07-31

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

Lancet：维持低剂量糖皮质激素治疗对低疾病活动度的类风湿关节炎患者症状控制更为有效

2020-07-27

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

AP&T: 定期使用质子泵抑制剂和女性类风湿性关节炎的风险

2020-07-21

ms4964546379600229 (审核中...)

前往app查看评论内容

#类风湿#

NEJM：PRIME细胞与类风湿性关节炎发作

2020-07-18

科室
- - 订阅+
  - 更多科室
工具
服务